About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyMidwest
Team (2)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
130
By Phase
PHASE2: 7PHASE1/PHASE2: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 8COMPLETED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05731050Lead Sponsor
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PHASE2Not yet recruiting
6 participants
Started: Jun 30, 2026 · Completed: Mar 31, 2028
NCT06226662Lead Sponsor
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
PHASE2Not yet recruiting
12 participants
Started: Jun 30, 2026 · Completed: Sep 30, 2028
NCT06887738Lead Sponsor
Study of NM8074 in Patients with Dermatomyositis (DM)
PHASE2Not yet recruiting
8 participants
Started: Jun 30, 2026 · Completed: Dec 31, 2028
NCT05646524Lead Sponsor
Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
PHASE2Not yet recruiting
12 participants
Started: Apr 30, 2026 · Completed: Sep 30, 2028
NCT05646563Lead Sponsor
Study of NM8074 in Adult PNH Patients with Inadequate Response to Soliris
PHASE2Not yet recruiting
12 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2028
Locations (1)
Headquarters
Cleveland, OH, United States
Map
Loading map...